The role of sirtuins in Alzheimer's disease
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 5, 16
- https://doi.org/10.3389/fnagi.2013.00016
Abstract
Sirtuins are highly conserved NAD+-dependent enzymes that were shown to have beneficial effects against age-related diseases. Alzheimer’s Disease (AD) is the most common neurodegenerative disorder associated with aging and the effects of sirtuins on AD have been investigated using different mouse and cell culture models. In most of these studies, it has been found that the overexpression of SIRT1 has protective effects against the AD phenotype. Therefore, designing therapeutics based on SIRT1 activity might be important to investigate treatment methods for this disease. In this review, we summarize the recent research regarding the roles of sirtuins and their potential roles in designing therapeutics for AD.Keywords
This publication has 28 references indexed in Scilit:
- Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric ActivatorsScience, 2013
- Mammalian Sirtuins: Biological Insights and Disease RelevanceAnnual Review Of Pathology-Mechanisms Of Disease, 2010
- Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 2009
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- SIRT1 transgenic mice show phenotypes resembling calorie restrictionAging Cell, 2007
- Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)Journal of Alzheimer's Disease, 2006
- Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie RestrictionJournal of Biological Chemistry, 2006
- Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic PerspectiveCell, 2005
- Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic modelsPublished by Elsevier ,2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002